» Articles » PMID: 28771023

Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus

Overview
Date 2017 Aug 4
PMID 28771023
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Several antiretrovirals (ART) have been coformulated as single tablet regimens (STR). Study objectives were to compare ART and non-ART adherence between STR and multiple tablet regimens (MTR) recipients, determine whether STR independently predicts ART adherence, and determine whether ART adherence influences non-ART adherence. A retrospective cohort study was performed among Upstate New York Veterans' Healthcare Administration (VISN-2) patients from 2000 to 2013. Inclusion criteria were age ≥18 years, human immunodeficiency virus (HIV) infection, receipt of ≥3 ART medications for ≥3 months, and available pharmacy refill records. The two study outcomes were adherence to ART medications and non-ART medications. Adherence was determined with pharmacy refill records that were used to calculate medication possession ratios. Among the 1202 subjects, there were 165 (13.7%) STR and 1037 (86.3%) MTR recipients. Mean ± standard deviation (SD) ART adherence was significantly higher for STR recipients (81.5% ± 15.3%) than MTR recipients (66.1% ± 21.1%), p < 0.001. Use of STR [adjusted odds ratio (aOR): 5.76, 95% confidence interval (CI): 3.84-8.65, p < 0.001] was independently associated with optimal (≥90%) adherence to ART. Mean ± SD non-ART adherence did not differ between STR (78.8% ± 15.6%) and MTR recipients (80.8% ± 16.0%), p = 0.17. Optimal adherence to ART medications (aOR: 2.30, 95% CI: 1.57-3.38, p < 0.001) was independently associated with optimal adherence to non-ART medications. The use of STRs are associated with optimal adherence to ART medications, but not directly associated with adherence to non-ART medications.

Citing Articles

Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV.

Kunimoto Y, Hikasa S, Ishihara M, Tsukiji M, Nobori K, Kimura T J Pharm Health Care Sci. 2024; 10(1):27.

PMID: 38840139 PMC: 11151521. DOI: 10.1186/s40780-024-00349-7.


Antiretroviral stewardship in a tertiary academic hospital: The need for a clinical pharmacist.

Bronkhorst E, Hattingh S, Poka M Health SA. 2024; 28:2135.

PMID: 38633911 PMC: 11022499. DOI: 10.4102/hsag.v28i0.2135.


Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era.

Ma J, Luu B, Ruderman S, Whitney B, Merrill J, Mixson L AIDS Care. 2023; 36(5):618-630.

PMID: 37419138 PMC: 10771542. DOI: 10.1080/09540121.2023.2223899.


Adherence to antiretroviral therapy and viral suppression: Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil.

Meiners M, Araujo Cruz I, de Toledo M Front Pharmacol. 2023; 14:1122018.

PMID: 37063259 PMC: 10102605. DOI: 10.3389/fphar.2023.1122018.


Medication adherence with fixed-dose free-equivalent combination therapies: Systematic review and meta-analysis.

Wei Q, Zhou J, Li H, Wang L, Wu Y, Ma A Front Pharmacol. 2023; 14:1156081.

PMID: 37033611 PMC: 10074603. DOI: 10.3389/fphar.2023.1156081.